[ Price : $8.95]
Three Epstein Becker Green attorneys analyze a new FDA draft guidance on communicating scientific information on unapproved uses o...[ Price : $8.95]
FDA approves a Medtronic PMA for its Symplicity Spyral renal denervation system for treating hypertension.[ Price : $8.95]
FDA delays a 12/16-expected review decision on a Bristol Myers Squibb and 2seventy bio supplemental BLA for Abecma (idecabtagene v...[ Price : $8.95]
Federal Register notice: FDA announces a 12/14 public meeting entitled Advancing the Development of Therapeutics Through Rare Dise...[ Price : $8.95]
Federal Register notice: FDA seeks information to better understand the status of trading partners interoperable systems and proce...[ Price : $8.95]
A new final rule outlines five standards that the agency says drug marketers must follow to ensure their direct-to-consumer advert...[ Price : $8.95]
Bayer stops its Phase 3 OCEANIC-AF study evaluating asundexian compared to apixaban (Bristol-Myers Squibbs Eliquis) in patients wi...[ Price : $8.95]
FDA warns healthcare professionals not to use Cardinal Health Monoject syringes with syringe pumps and patient-controlled analgesi...